loading page

Left Ventricular Assist Devices in The Elderly: Marching Forward With Cautions
  • Parag Patel,
  • Basar Sareyyupoglu,
  • Si Pham
Parag Patel
Mayo Clinic
Author Profile
Basar Sareyyupoglu
Mayo Clinic Florida
Author Profile
Si Pham
Mayo Clinic's Campus in Florida
Author Profile

Abstract

Congestive heart failure is highly prevalent in the elderly population and left ventricular assist device has been increasingly used in this population. LVAD therapy is more costly than medical treatment but it increases the survival and quality of life of the elderly patients with low disease acuity. Therefore careful selection of candidates and implementation of LVAD therapy earlier in the course of the disease is crucial to improve outcomes. With the technical advances and improvement in clinical management, the financial burden of LVAD therapy in the elderly will become less, making this therapy more economically feasible.

Peer review status:ACCEPTED

15 Sep 2020Submitted to Journal of Cardiac Surgery
15 Sep 2020Assigned to Editor
15 Sep 2020Submission Checks Completed
15 Sep 2020Review(s) Completed, Editorial Evaluation Pending
15 Sep 2020Editorial Decision: Accept